CALC - Company ID 0001534133
The table below shows CalciMedica, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $2.10M | $3.48M | $3.85M | $4.05M | $4.22M | $3.55M |
| SG&A |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.91M |
| $2.13M |
| $1.77M |
| $2.57M |
| $2.27M |
| $2.19M |
| Operating income | -$4.01M | -$5.61M | -$5.62M | -$6.62M | -$6.50M | -$5.74M |
| Income tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | -$7.65M | $4.98M | -$7.80M | -$5.96M | -$5.04M | -$5.62M |
| EPS (diluted) | -$0.45 | $0.30 | -$0.52 | -$0.40 | -$0.36 | -$0.50 |